Bio-Techne Balance Sheet
NASDAQ: TECHHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Bio-Techne financial position
At the end of fiscal 2026, Bio-Techne reported total assets of $2.59 billion, up 1.1% from a year earlier against total liabilities of $478.5 million. Shareholders' equity stood at $2.11 billion, or 81.5% of assets. The company held $264.7 million in cash and equivalents against $200.0 million of debt, a net cash position of $64.7 million.
The current ratio (current assets divided by current liabilities) was 4.55, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.09.
Summary generated from market data by MetaCap's automated system. Methodology
Bio-Techne balance sheet (annual)
| Fiscal year (USD) | FY 20262026-06-30 | FY 20252025-06-30 | FY 20242024-06-30 | FY 20232023-06-30 | FY 20222022-06-30 | FY 20212021-06-30 | FY 20202020-06-30 | FY 20192019-06-30 | FY 20182018-06-30 | FY 20172017-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 264.71M | 162.19M | 151.79M | 180.57M | 172.57M | 199.09M | 146.63M | 100.89M | 121.99M | 91.61M |
| Short-Term Investments | — | — | 1.07M | 23.74M | 74.46M | 32.46M | 124.27M | 65.15M | 59.76M | 66.10M |
| Receivables | 216.59M | 206.88M | 241.39M | 218.47M | 194.55M | 145.38M | 122.53M | 137.47M | 120.30M | 116.83M |
| Inventory | 195.74M | 189.45M | 179.73M | 171.64M | 141.12M | 116.75M | 103.15M | 91.05M | 85.65M | 85.65M |
| Total Current Assets | 744.40M | 608.30M | 617.42M | 621.48M | 605.56M | 510.61M | 520.92M | 412.61M | 398.37M | 348.02M |
| Property, Plant & Equipment | 231.84M | 245.72M | 251.15M | 226.20M | 223.24M | 207.91M | 176.83M | 154.04M | 145.35M | 135.12M |
| Goodwill | 975.36M | 980.93M | 972.66M | 872.74M | 822.10M | 843.07M | 728.31M | 732.67M | 597.89M | 579.03M |
| Intangible Assets | 303.46M | 365.60M | 507.08M | 534.64M | 531.52M | 615.97M | 516.54M | 579.43M | 446.33M | 452.04M |
| Total Assets | 2.59B | 2.56B | 2.70B | 2.64B | 2.29B | 2.26B | 2.03B | 1.88B | 1.59B | 1.56B |
| Accounts Payable | 26.70M | 25.31M | 37.97M | 25.68M | 33.87M | 29.38M | 23.09M | 16.21M | 18.45M | 16.86M |
| Short-Term Debt | — | — | — | — | 12.50M | 12.50M | 12.50M | 12.50M | — | — |
| Total Current Liabilities | 163.70M | 175.85M | 159.38M | 128.51M | 176.02M | 152.28M | 106.67M | 101.98M | 79.51M | 135.52M |
| Long-Term Debt | 200.00M | 346.00M | 319.00M | 350.00M | 243.41M | 328.83M | 344.24M | 492.66M | 339.00M | 343.77M |
| Total Liabilities | 478.50M | 639.06M | 635.02M | 672.18M | 593.79M | 691.72M | 646.40M | 718.82M | 514.14M | 608.59M |
| Shareholders' Equity | 2.11B | 1.92B | 2.07B | 1.97B | 1.70B | 1.56B | 1.38B | 1.17B | 1.08B | 949.63M |
| Retained Earnings | 1.14B | 1.07B | 1.33B | 1.31B | 1.12B | 1.09B | 1.06B | 931.93M | 876.93M | 799.03M |
| Total Debt | 200.00M | 346.00M | 319.00M | 350.00M | 255.91M | 341.33M | 356.74M | 505.16M | 339.00M | 343.77M |
| Net Cash (Debt) | 64.71M | -183.81M | -166.14M | -145.69M | -8.88M | -109.77M | -85.85M | -339.13M | -157.25M | -186.06M |
| Shares Outstanding | 156.10M | 154.97M | 158.22M | 157.64M | 156.64M | 38.96M | 38.45M | 37.93M | 37.61M | 37.36M |
This table shows 10 annual periods of Bio-Techne's balance sheet, from FY 2026 back to FY 2017, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow TECH's reporting calendar. What is a balance sheet?